The Indian women’s T20 team captain Harmanpreet Kaur has tested positive for COVID-19 and is experiencing mild symptoms.
Kaur, who did not play in the T20 series against South Africa in Lucknow after injuring herself in the fifth ODI on March 17, got herself tested on Monday after developing mild fever.
"She is self-isolating at home. She got tested yesterday and the report came positive today morning. She had mild fever since four days so thought it was best to get tested. She is doing fine otherwise and should recover soon,” a source close to the player told PTI.
"She was getting tested regularly during the South Africa series so she must have caught the virus after that only,” the source added.
Kaur had shown decent form in the ODIs scoring a half-century and a 40.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.